1. Home
  2. ADMA vs HUN Comparison

ADMA vs HUN Comparison

Compare ADMA & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.69

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$13.45

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
HUN
Founded
2004
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
ADMA
HUN
Price
$10.69
$13.45
Analyst Decision
Buy
Hold
Analyst Count
3
11
Target Price
$28.00
$12.09
AVG Volume (30 Days)
9.5M
5.4M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
2.58%
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$42,219,783.00
$5,683,000,000.00
Revenue This Year
$27.46
$3.04
Revenue Next Year
$22.11
$5.31
P/E Ratio
$17.49
N/A
Revenue Growth
43.85
N/A
52 Week Low
$7.21
$7.30
52 Week High
$25.67
$14.38

Technical Indicators

Market Signals
Indicator
ADMA
HUN
Relative Strength Index (RSI) 42.02 56.85
Support Level $7.21 $10.41
Resistance Level $16.30 $14.38
Average True Range (ATR) 0.61 0.72
MACD 0.29 0.11
Stochastic Oscillator 97.74 66.20

Price Performance

Historical Comparison
ADMA
HUN

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: